News
Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...
AbbVie (ABBV) announced a $195 million investment in its North Chicago manufacturing facility to boost domestic API ...
AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...
1d
Pharmaceutical Technology on MSNAbbVie expands North Chicago API production with $195m investment
AbbVie is investing $195m to strengthen domestic API production, with the expansion of its manufacturing plant in North ...
In Westport, an Irish town transformed by a pharmaceutical plant that manufactures the world’s Botox, there are fears President Donald Trump’s new tariffs may hit hard.
AbbVie Inc.'s Q2 2025 results showcase Skyrizi & Rinvoq's growth, strong finances, and a promising pipeline. Click for my ...
The company’s commitment to its North Chicago, Ill. plant is part of a previously announced $10 billion capital investment ...
The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.
AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, ...
AbbVie, a global leader in life sciences, announced Tuesday the company’s is investing $195 million to expand its North ...
AbbVie (NYSE:ABBV) invests $195M in North Chicago for API production, boosting U.S. pharmaceutical manufacturing. Read more ...
As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results